Related Experiment Video
Updated: Apr 25, 2026

10:16
Production and Targeting of Monovalent Quantum Dots
Published on: October 23, 2014
26.4K
Multifunctional graphene quantum dots for simultaneous targeted cellular imaging and drug delivery
Xiaojuan Wang1, Xing Sun1, Jun Lao1
1State Key Laboratory of Heavy Oil Processing and Center for Bioengineering and Biotechnology, China University of Petroleum (East China), 66 Changjiang West Road, Qingdao Economic Development Zone, Qingdao 266555, China.
Colloids and Surfaces. B, Biointerfaces
|August 18, 2014
Summary
Ligand-modified graphene quantum dots (GQDs) enable targeted cancer cell labeling and drug delivery. This nanoassembly allows real-time monitoring of drug uptake and release, reducing toxicity to normal cells.
Area of Science:
- Nanotechnology
- Biomedical Engineering
- Materials Science
Background:
- Graphene quantum dots (GQDs) offer unique optical and electronic properties for biomedical applications.
- Developing multifunctional nanomaterials for simultaneous cell labeling, drug delivery, and monitoring is a key challenge.
- Targeted delivery systems are crucial for enhancing cancer therapy efficacy and minimizing side effects.
Purpose of the Study:
- To synthesize and characterize folic acid (FA)-conjugated GQDs for targeted drug delivery.
- To evaluate the nanoassembly's capability for selective cancer cell labeling and drug delivery.
- To investigate the real-time monitoring of cellular uptake and drug release dynamics.
Main Methods:
- Synthesis of FA-conjugated GQDs and loading with doxorubicin (DOX) to create a DOX-GQD-FA nanoassembly.
- Utilizing the inherent fluorescence of GQDs for real-time tracking of nanoassembly uptake and drug release.
- In vitro experiments to assess selective cell targeting, cellular internalization mechanisms (receptor-mediated endocytosis), and cytotoxicity.
Main Results:
- The DOX-GQD-FA nanoassembly successfully discriminated between cancer (HeLa) and normal cells.
- Efficient and targeted delivery of DOX to HeLa cells was achieved via receptor-mediated endocytosis.
- Real-time monitoring confirmed rapid internalization and prolonged drug release, with reduced toxicity to non-target cells.
Conclusions:
- Ligand-modified GQDs serve as a versatile platform for multifunctional nanomedicine.
- The DOX-GQD-FA nanoassembly demonstrates high potential for targeted cancer therapy with improved safety profiles.
- This approach offers a promising strategy for simultaneous cancer cell targeting, drug delivery, and in situ monitoring.

